Usefulness of [18F]-FDOPA pet as an adjunct to [ 18F]-FDG pet in the imaging of small cell lung carcinoma. Preliminary results;La TEP à la [18F]-FDOPA dans l'imagerie des carcinomes bronchiques à petites cellules: Comparaison avec l'imagerie conventionnelle et la TEP au [18F]-FDG. Résultats préliminaires

Medecine Nucleaire

Volumn 27, Issue 7, 2003, Pages 353-358

  Jacob, Thierry ^a   Grahek, D ^a   Kerrou, K ^a   Aide, N ^a   Montravers, F ^a   Younsi, N ^a   Balogova, S ^a   De Beco, V ^a   Colombet, C ^a   Talbot, J N ^a  

^a HÔPITAL TENON   (France)

Author keywords

18F FDG; 18F FDOPA; Positron Emission Tomography (PET); Small Cell Lung Carcinoma

Indexed keywords

ALPHA FLUOROMETHYLDOPA; CHROMOGRANIN A; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; NERVE CELL ADHESION MOLECULE; SYNAPTOPHYSIN;

ADULT; AGED; APPARATUS; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; HUMAN; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LUNG SMALL CELL CANCER; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS;

EID: 0141928163     PISSN: 09281258     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Mountain C.F. Revisions in the International System for staging lung cancer. Chest 1997; 111 (6): 1710-1717.
2. Mountain C.F. A new international staging system for lung cancer. Chest 1986; 89 (Suppl 4): 225-233.
3. Arriagada R., Le Chavalier T., Pignon J.P. et al. Initial chemotherapeutic doses and survival in patient with limited small-cell lung cancer. N Engl J Med 1993; 329 (25): 1848-1852.
4. Comis R.L., Friedland D.M., Good B.C. Small-cell lung cancer: a perspective on the past and a preview of the future. Oncology (Huntingt) 1998; 12 (1 suppl 2): 44-50.
5. Wilbur A.F. Diagnosis of lung cancer. Pathology of invasive and preinvasive neoplasia. Chest 2000; 117: 80S-89S.
6. Hoegerle S., Altehoefer C., Ghanem N. et al. Whole-body 18F-DOPA PET for detection of gastrointestinal carcinoid tumors. Radiology 2001; 220 (2): 373-380.
7. Hoegerle S., Altehoefer C., Ghanem N. et al. 18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels. Eur J Nucl Med 2001; 28: 64-71.
8. Ahlström H., Eriksson B., Öberg K. et al. Pancreatic neuroendocrine tumors: diagnosis with PET. Radiology 1995; 195: 333-337
9. Bergström M., Eriksson B., Öberg K. et al. In vivo demonstration of enzyme activity in endocrine pancreatic tumors: decarboxylation of carbon-11-DOPA to carbon-11-dopamine. J Nucl Med 1996; 37: 32-37.
10. Simon G.R., Wagner H. Small cell lung cancer. GR.. Chest 2003; 123: 259S-271.
11. Schumacher T., Brink I., Mix M. et al. FDG-PET imaging for the staging and follow-up of small cell lung cancer. Eur JNucl Med 2001; 28: 483-488.
12. Hauber H.P., Bohuslavizki K.H., Lund C.H. et al. Positron emission tomography in the staging of small-cell lung cancer. A preliminary study. Chest 2001; 119: 950-954.
13. Chin R., Mc Cain T.W., Miller A.A. et al. Whole body FDG-PET for the evaluation and staging of small cell lung cancer: a preliminary study. Lung Cancer 2002; 37: 1-6.
14. Deshan S.Z., Valdivia A.Y., Blaufox D. et al. 18F-Fluorodeoxyglucose positron emission tomography in small-cell lung cancer. Semin Nucl Med 2002; 32 (4): 272-275.
15. Griffeth L.K., Dehdashti K.M., Simpson J.R. et al. Brain metastases from non-central nervous system tumors: evaluation with PET. Radiology 1993; 186: 37-44.
16. Rohren E.M., Provenzale J.M., Barboriak D.P. et al. Screening for cerebral metastases with FDG-PET in patients undergoing whole-body staging of non-central nervous system malignancy. Radiology 2003; 226 (1): 181-187.
17. Szabo M., Marosi C., Asenbaum S. et al. 18F-Fluorodopa is equivalent to 11C-methionine in brain tumour imaging. J Nucl Med 2002; 43 (5) suppl: 113P.